↓ Skip to main content

A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED…

Overview of attention for article published in Trials, October 2022
Altmetric Badge

Mentioned by

news
5 news outlets
blogs
1 blog
policy
1 policy source
twitter
3 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network
Published in
Trials, October 2022
DOI 10.1186/s13063-022-06791-y
Pubmed ID
Authors

Julia M. Neuhann, Jannik Stemler, Antonio Carcas, Jesús Frías-Iniesta, Ullrich Bethe, Sarah Heringer, Lea Tischmann, Marouan Zarrouk, Arnd Cüppers, Franz König, Martin Posch, Oliver A. Cornely

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 13%
Professor 1 7%
Student > Ph. D. Student 1 7%
Student > Master 1 7%
Student > Postgraduate 1 7%
Other 0 0%
Unknown 9 60%
Readers by discipline Count As %
Medicine and Dentistry 4 27%
Nursing and Health Professions 1 7%
Biochemistry, Genetics and Molecular Biology 1 7%
Unknown 9 60%